Tag Archives: NIH

Moving AHRQ Into The NIH: New Beginning Or Beginning Of The End?

The proposal to relocate AHRQ within the NIH is a threatening change, but under the right conditions a reorganization could represent a new beginning with an opportunity to refocus within a larger new home.

March 27, 2017

What Three Decades Of Pandemic Threats Can Teach Us About The Future

The U.S. government will need to continue its investment to combat pandemic diseases wherever they emerge, and to conduct crucial research and development of medical countermeasures to rapidly respond to emerging infectious disease threats.

February 9, 2017

The Current 21st Century Cures Legislation Is Still A Bad Deal For Patients

We believe the bill’s potential benefits and modestly enhanced funding for scientific advancement are far outweighed by the increased risk of patient harm, and added pressure on the FDA to rush new products to market without adequate evidence.

November 30, 2016

A Reprieve For Women: Embracing Inclusive Scientific Research

An ambitious new clinical trial funded by the NIH called REPRIEVE prioritizes the analysis of sex differences in the onset, severity, and course of HIV and heart disease.

September 13, 2016

Congress Shouldn’t Pass The 21st Century Cures Act In A Summer Rush

Congress is set to adjourn for an extended election-year summer recess on July 15, and time is running out to pass the 21st Century Cures Act. That’s a good thing, because the legislation, while containing some useful measures, is flawed, and Congress should postpone consideration until 2017.

July 11, 2016

Reexamining Chronic Fatigue Syndrome Research And Treatment Policy

Two recent developments have provided some degree of optimism to people with chronic fatigue syndrome, heralding the possibility of changes in research and treatment policies. One point must not be overlooked: patients can possess more wisdom about their condition than researchers and policymakers.

February 4, 2016

To Support Physician Decision-Making, Re-Evaluate Industry Funding Of Science

In 1984, the New England Journal of Medicine began requiring authors of research papers to disclose financial relationships with the pharmaceutical or device industry. The policy was controversial then, and even a decade later still faced criticism.

July 16, 2015

Seven Big Ideas From Spotlight Health

A few of us from Health Affairs were lucky enough to attend Spotlight Health at the Aspen Ideas Festival in Aspen, Colorado. Here are just seven of the ideas that surprised us, impressed us, and even made us reexamine what we thought we already knew.

July 2, 2015

To Spur Medical Innovation, Make Corporate Cheaters Pay

The past decade has seen a relatively constant rate of newly approved drugs every year. The number has even jumped in the past few years. Yet, despite such encouraging trends, we are actually facing a crisis in drug innovation today.

April 30, 2015